Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: State-of-the-Art HIV Care and Prevention

79 - What's the latest data and experience on LAI treatment and prevention?

Thursday, October 17, 2024
10:30 AM – 10:50 AM US PT
Location: Concourse 151
Disclosure(s):
Raphael J. Landovitz, MD, MSc: Gilead Sciences: Advisor/Consultant (Ongoing), Scientific Advisory Board member (Ongoing); Merck and Company, Inc.: Advisor/Consultant (Ongoing), Scientific Advisory Board member (Ongoing); RedQueen Therapeutics: Advisor/Consultant (Ongoing), Scientific Advisory Board member (Ongoing); Viiv Healthcare: Advisor/Consultant (Ongoing), Scientific Advisory Board member (Ongoing)